Skip to main content
SpringerLink
Log in

JAK2V617F mutational frequency in polycythemia vera: 100%, >90%, less?

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005; 434: 1144–1148.

    Article  CAS  Google Scholar 

  2. Nelson ME, Steensma DP . JAK2 V617F in myeloid disorders: what do we know now, and where are we headed? Leuk Lymphoma 2006; 47: 177–194.

    Article  CAS  Google Scholar 

  3. Greiner TC . Diagnostic assays for the JAK2 V617F mutation in chronic myeloproliferative disorders. Am J Clin Pathol 2006; 125: 651–653.

    Article  CAS  Google Scholar 

  4. Jones AV, Silver RT, Waghorn K, Curtis C, Kreil S, Zoi K et al. Minimal molecular response in polycythemia vera patients treated with imatinib or interferon alpha. Blood 2006; 107: 3339–3341.

    Article  CAS  Google Scholar 

  5. Tefferi A, Lasho TL, Schwager SM, Strand JS, Elliott M, Mesa R et al. The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera. Cancer 2006; 106: 631–635.

    Article  CAS  Google Scholar 

  6. McClure R, Mai M, Lasho T . Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disorders. Leukemia 2006; 20: 168–171.

    Article  CAS  Google Scholar 

  7. Jelinek J, Oki Y, Gharibyan V, Bueso-Ramos C, Prchal JT, Verstovsek S et al. JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia. Blood 2005; 106: 3370–3373.

    Article  CAS  Google Scholar 

  8. Jones AV, Kreil S, Zoi K, Waghorn K, Curtis C, Zhang L et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 2005; 106: 2162–2168.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    S Verstovsek

  2. Leukemia and Myeloproliferative Center, Weill Medical College of Cornell University, New York, NY, USA

    R T Silver

  3. Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, UK

    N C P Cross

  4. Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN, USA

    A Tefferi

Authors
  1. S Verstovsek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R T Silver
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N C P Cross
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Tefferi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Tefferi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verstovsek, S., Silver, R., Cross, N. et al. JAK2V617F mutational frequency in polycythemia vera: 100%, >90%, less?. Leukemia 20, 2067 (2006). https://doi.org/10.1038/sj.leu.2404379

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404379

  • Springer Nature Limited

This article is cited by

Search

Navigation